Work

BCL2L11 (BIM) deletion polymorphism, rather than BIM SNP, is an effective predictor of early molecular relapse after ABL tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

FWCI: 0.381
Cites: 5
Cited by: 2
Related to: 10